Ameriprise’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,235
| Closed | -$10.3K | – | 3942 |
|
|
2023
Q2 | $10.3K | Buy |
2,235
+115
| +5% | +$529 | ﹤0.01% | 3889 |
|
|
2023
Q1 | $15K | Sell |
2,120
-25
| -1% | -$177 | ﹤0.01% | 3900 |
|
|
2022
Q4 | $14K | Sell |
2,145
-150
| -7% | -$979 | ﹤0.01% | 3913 |
|
|
2022
Q3 | $34K | Buy |
2,295
+1,605
| +233% | +$23.8K | ﹤0.01% | 3901 |
|
|
2022
Q2 | $12K | Sell |
690
-7
| -1% | -$122 | ﹤0.01% | 3860 |
|
|
2022
Q1 | $21K | Buy |
697
+13
| +2% | +$392 | ﹤0.01% | 3901 |
|
|
2021
Q4 | $30K | Sell |
684
-5
| -0.7% | -$219 | ﹤0.01% | 3915 |
|
|
2021
Q3 | $49K | Buy |
+689
| New | +$49K | ﹤0.01% | 3815 |
|
|
2021
Q1 | – | Sell |
-3,424
| Closed | -$164K | – | 3875 |
|
|
2020
Q4 | $164K | Sell |
3,424
-25
| -0.7% | -$1.2K | ﹤0.01% | 3640 |
|
|
2020
Q3 | $96K | Buy |
3,449
+20
| +0.6% | +$557 | ﹤0.01% | 3641 |
|
|
2020
Q2 | $131K | Sell |
3,429
-75
| -2% | -$2.87K | ﹤0.01% | 3557 |
|
|
2020
Q1 | $172K | Buy |
3,504
+78
| +2% | +$3.83K | ﹤0.01% | 3466 |
|
|
2019
Q4 | $154K | Sell |
3,426
-15
| -0.4% | -$674 | ﹤0.01% | 3608 |
|
|
2019
Q3 | $145K | Buy |
3,441
+76
| +2% | +$3.2K | ﹤0.01% | 3600 |
|
|
2019
Q2 | $168K | Hold |
3,365
| – | – | ﹤0.01% | 3590 |
|
|
2019
Q1 | $266K | Buy |
+3,365
| New | +$266K | ﹤0.01% | 3467 |
|